These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Deeken JF; Figg WD; Bates SE; Sparreboom A Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598 [TBL] [Abstract][Full Text] [Related]
14. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment. Mathijssen RH; van Schaik RH Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399 [TBL] [Abstract][Full Text] [Related]
15. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions. Wang L; Weinshilboum R Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163 [TBL] [Abstract][Full Text] [Related]
16. Cancer pharmacogenetics. Marsh S Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241 [TBL] [Abstract][Full Text] [Related]
17. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs]. Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632 [TBL] [Abstract][Full Text] [Related]
18. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes. van Schaik RH Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics. Going from genome to pill. Service RF Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283 [No Abstract] [Full Text] [Related]